<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112799">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01634815</url>
  </required_header>
  <id_info>
    <org_study_id>5244</org_study_id>
    <nct_id>NCT01634815</nct_id>
  </id_info>
  <brief_title>Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization</brief_title>
  <acronym>ELIT</acronym>
  <official_title>Evaluation of Local Capillary Blood Lactate in Chronic Critical Ischemia of Lower Limb Before and After Revascularization.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of a new biological criterion, the local capillary blood lactates to optimize the
      management of patients with chronic critical ischemia requiring revascularization fast.
      Potential use in terms of capillary blood lactate as a diagnostic indicator of recurrent
      ischemia in a limb revascularized.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Report Capillary blood lactate To Finger Capillary blood lactate (LCO / LCD)</measure>
    <time_frame>48 hours</time_frame>
    <description>Report Capillary blood lactate To Finger Capillary blood lactate (LCO / LCD) before revascularization of the lower limb in chronic critical limb ischemia (considered positive if&gt; 2).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The decrease in the ratio LCO/LCD</measure>
    <time_frame>48 hours</time_frame>
    <description>The decrease in the ratio LCO / LCD in the immediate aftermath of revascularization</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Critical Ischemia</condition>
  <arm_group>
    <arm_group_label>lactate group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>The Edge</intervention_name>
    <description>measuring blood lactate</description>
    <arm_group_label>lactate group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemia Chronic critical lower limb revascularization procedure requiring fast.

          -  Written consent informed patient age greater than or equal to 18

        Exclusion Criteria:

          -  Presence of an inflammatory or infectious (erysipelas) in the ischemic member.

          -  Patients at risk for diabetic foot ie, as defined by the HAS (preventing diabetic
             foot, 2007)

               -  presence of sensory neuropathy, and / or

               -  foot deformities (hallux valgus, hammer toes or claw, prominence of the
                  metatarsal heads), and / or

               -  history of foot ulceration, and / or

               -  antecedent of one of these factors (ie antécedant diabetic foot).

          -  Necrosis of the toes.

          -  Participation in another clinical research protocol.

          -  Presence of peripheral arterial disease in the bilateral upper limbs.

          -  Patient in shock whatever the cause.

          -  Presence of hepatic failure.

          -  Too impaired general condition (bedridden, dementia, ...)

          -  Refusal of the patient to participate in the study

          -  Protected patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Diemunsch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>not affiliated</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Diemunsch, MD</last_name>
    <phone>03 88 12 70 76</phone>
    <email>pierre.diemunsch@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric Noll, MD</last_name>
    <phone>03 88 11 67 68</phone>
    <email>eric.noll@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique de l'Orangerie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe PLOBNER, MD</last_name>
      <phone>(0)3 88 56 73 00</phone>
      <phone_ext>+33</phone_ext>
      <email>p.plobner@free.fr</email>
    </contact>
    <investigator>
      <last_name>Sorin POPESCU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe PLOBNER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin BRODATY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg, Service d' Anesthésie Réanimation Chirurgicale</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Diemunsch, MD</last_name>
      <phone>03 88 12 70 76</phone>
      <email>pierre.diemunsch@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Eric Noll, MD</last_name>
      <phone>03 88 11 67 68</phone>
      <email>eric.noll@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre Diemunsch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Noll, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard Geny, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien Pottecher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Collange, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabien Thaveau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Levy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nabil Chakfe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Georges Kretz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boris Aleil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrien Thibaud, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <lastchanged_date>June 22, 2015</lastchanged_date>
  <firstreceived_date>July 2, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
